![]() |
|
|
Vol. 16, Issue 3, 1527-1542, March 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* Institute of Basic Medical Sciences, Department of Biochemistry, University of Oslo, Oslo N-0317, Norway;
Division of Biology and Cancer Center, University of California, San Diego, La Jolla, CA 92090-0322; and
AmProx Incorporated, Carlsbad, CA 92009
Submitted June 21, 2004;
Accepted December 22, 2004
Monitoring Editor: Tony Hunter
cAMP exerts an antiproliferative effect on a number of cell types including lymphocytes. This effect of cAMP is proposed to be mediated by its ability to inhibit G1/S transition. In this report, we provide evidence for a new mechanism whereby cAMP might inhibit cellular proliferation. We show that elevation of intracellular levels of cAMP inhibits DNA replication and arrests the cells in S phase. The cAMP-induced inhibition of DNA synthesis was associated with the increased binding of p21Cip1 to Cdk2-cyclin complexes, inhibition of Cdk2 kinase activity, dephosphorylation of Rb, and dissociation of PCNA from chromatin in S phase cells. The ability of cAMP to inhibit DNA replication and trigger release of PCNA from chromatin required Rb and p21Cip1 proteins, since both processes were only marginally affected by increased levels of cAMP in Rb-/- and p21Cip1-/- 3T3 fibroblasts. Importantly, the implications of cAMP-induced inhibition of DNA synthesis in cancer treatment was demonstrated by the ability of cAMP to reduce apoptosis induced by S phasespecific cytotoxic drugs. Taken together, these results demonstrate a novel role for cAMP in regulation of DNA synthesis and support a model in which activation of cAMP-dependent signaling protects cells from the effect of S phasespecific antitumor agents.
Abbreviations used: cAMP, cyclic AMP; Rb, retinoblastoma protein; Cdk, cyclin-dependent kinase; CKI, cyclin-dependent kinase inhibitor; PCNA, proliferating cell nuclear antigen; RFC, replication factor C; pol
, DNA polymerase
; CPT, camptothecin; 5-FU, 5-fluorouracil; HU, hydroxyurea; PAC, paclitaxel; VB, vinblastine; PI, propidium iodide; FITC, fluorescein isothiocyanate; BrdU, bromodeoxyuridine; MEFs, mouse embryo fibroblasts; Aph, aphidicolin; IBMX, 3-isobutyl-1-methylxantine; PGE2, prostaglandin E2; CTX, cholera toxin; MNase, micrococcal nuclease.
Address correspondence to: Soheil Naderi (soheil.naderi{at}basalmed.uio.no).
This article has been cited by other articles:
![]() |
H. Ugland, A. C. Boquest, S. Naderi, P. Collas, and H. K. Blomhoff cAMP-mediated Induction of Cyclin E Sensitizes Growth-arrested Adipose Stem Cells to DNA Damage-induced Apoptosis Mol. Biol. Cell, December 1, 2008; 19(12): 5082 - 5092. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. McEwan, V. G. Brunton, G. S. Baillie, N. R. Leslie, M. D. Houslay, and M. C. Frame Chemoresistant KM12C Colon Cancer Cells Are Addicted to Low Cyclic AMP Levels in a Phosphodiesterase 4-Regulated Compartment via Effects on Phosphoinositide 3-Kinase Cancer Res., June 1, 2007; 67(11): 5248 - 5257. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ertesvag, H.-C. Aasheim, S. Naderi, and H. K. Blomhoff Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK Blood, May 1, 2007; 109(9): 3865 - 3872. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Braden, J. M. Lenihan, Z. Lan, K. S. Luce, W. Zagorski, E. Bosco, M. F. Reed, J. G. Cook, and E. S. Knudsen Distinct Action of the Retinoblastoma Pathway on the DNA Replication Machinery Defines Specific Roles for Cyclin-Dependent Kinase Complexes in Prereplication Complex Assembly and S-Phase Progression Mol. Cell. Biol., October 15, 2006; 26(20): 7667 - 7681. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Engedal, T. Gjevik, R. Blomhoff, and H. K. Blomhoff All-trans Retinoic Acid Stimulates IL-2-Mediated Proliferation of Human T Lymphocytes: Early Induction of Cyclin D3. J. Immunol., September 1, 2006; 177(5): 2851 - 2861. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Knudsen and K. E. Knudsen Retinoblastoma tumor suppressor: where cancer meets the cell cycle. Experimental Biology and Medicine, July 1, 2006; 231(7): 1271 - 1281. [Abstract] [Full Text] [PDF] |
||||